Pennina Safer
Plus aucun poste en cours
Profil
Dr. Pennina Safer comes to Medica after two years at Concord Ventures where she was part of the Healthcare investment team, and two years with an Israeli biotech start-up, CBD Technologies.
Pennina brings significant experience from the US biotech industry, including 14 years at Genetics Institute, a Boston - area based biotechnology company which was acquired by American Home Products for $1B.
While at GI, she held a range of positions including Director, Research Technology Acquisition.
Pennina received her PhD in Human Genetics from Yale University, and did a post-doctoral fellowship at the Roche Institute of Molecular Biology.
Anciens postes connus de Pennina Safer
| Sociétés | Poste | Fin |
|---|---|---|
| GLOBEIMMUNE, INC. | Directeur/Membre du Conseil | 30/09/2014 |
CBD Technologies, Inc.
 CBD Technologies, Inc. TextilesProcess Industries Part of FuturaGene Ltd., CBD Technologies, Inc. provides biotechnology for forest improvement and the development of biologically-based, clean processes for paper manufacturing. The company is based in Bergenfield, NJ. The company was founded by Jonathan Joels, Oded Shoseyov. CBD Technologies was acquired by FuturaGene Ltd. on December 20, 2006 for $4.28 million. | Directeur Technique/Scientifique/R&D | 01/09/2000 |
Concord Venture Management Ltd.
 Concord Venture Management Ltd. Investment ManagersFinance Concord Venture Management Ltd. (Concord) is a venture capital firm founded in 1992 by Yair Safrai and Matty Karp. The firm is headquartered in Herzelia, Israel. | Corporate Officer/Principal | - |
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | - |
ImmunArray Ltd.
 ImmunArray Ltd. BiotechnologyHealth Technology ImmunArray Ltd. develops novel in-vitro diagnostic tests. Its products support a personalized medicine approach and IAL's first product family will provide tests for diagnosis, prognosis and therapeutic guidance of autoimmune diseases and for improving transplantation medicine. The firm is in the process of developing its first product family of blood tests for screening, detection and monitoring of autoimmune diseases and transplant rejection. The company was founded by Eli Sahar & Irun Cohen in 2006 and is headquartered in Rehovot, Israel. | Directeur des opérations | - |
Formation de Pennina Safer
| Yale University | Doctorate Degree |
| Brooklyn College | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| PAINREFORM LTD. | Health Technology |
| GLOBEIMMUNE, INC. | Health Technology |
| Entreprise privées | 5 |
|---|---|
Medica Venture Partners
 Medica Venture Partners Investment ManagersFinance Medica Venture Partners (Medica Venture Partners) is a venture capital firm founded in 1995 by Yuval Binur, Ehud Geller and Jonathan Fleming. The firm is headquartered in Israel. | Finance |
CBD Technologies, Inc.
CBD Technologies, Inc. TextilesProcess Industries Part of FuturaGene Ltd., CBD Technologies, Inc. provides biotechnology for forest improvement and the development of biologically-based, clean processes for paper manufacturing. The company is based in Bergenfield, NJ. The company was founded by Jonathan Joels, Oded Shoseyov. CBD Technologies was acquired by FuturaGene Ltd. on December 20, 2006 for $4.28 million. | Process Industries |
ImmunArray Ltd.
ImmunArray Ltd. BiotechnologyHealth Technology ImmunArray Ltd. develops novel in-vitro diagnostic tests. Its products support a personalized medicine approach and IAL's first product family will provide tests for diagnosis, prognosis and therapeutic guidance of autoimmune diseases and for improving transplantation medicine. The firm is in the process of developing its first product family of blood tests for screening, detection and monitoring of autoimmune diseases and transplant rejection. The company was founded by Eli Sahar & Irun Cohen in 2006 and is headquartered in Rehovot, Israel. | Health Technology |
Genetics Institute LLC
Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. | Health Technology |
Concord Venture Management Ltd.
Concord Venture Management Ltd. Investment ManagersFinance Concord Venture Management Ltd. (Concord) is a venture capital firm founded in 1992 by Yair Safrai and Matty Karp. The firm is headquartered in Herzelia, Israel. | Finance |